Medlab Clinical Ltd. (Medlab) announced to update a new initiative with UNSW Sydney. Medlab is entering into a laboratory collaboration-space lease agreement with the UNSW, Sydney in early August. This will build on current collaborations Medlab, and UNSW are working on ­ namely the NanoCelle® RNA nasal delivery research program.

Medlab announced that it has a laboratory located in the UNSW School of Biotechnology and Biomolecular Sciences (BABS), which is one of Australia's most prestigious schools of scientific research and teaching. Medlab is impressed by the progress of the current collaboration with UNSW's RNA Institute and the Woolcock Institute to develop nasal spray delivered RNA vaccines and antiviral treatments; and also advance nasal spray delivered insulin. These collaborations are leveraging Medlab Clinicals NanoCelle® delivery technology.

Closure of the Alexandria facility, the opening of pharmaceutical facilities in Botany [inclusive of warehousing, secure drug vaults, stability chambers, and retention sampling areas] and the laboratory lease with UNSW, will provide Medlab significant operational expenditure savings and new research development capabilities and opportunities.